Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood. - Wikidata - awgldk - TriplyDB

Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood.

Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood.

http://www.wikidata.org/entity/Q30480013

about

Multiple Aspects of Gene Dysregulation in Huntington's Disease The choreography of neuroinflammation in Huntington's disease Using gene expression signatures to identify novel treatment strategies in gulf war illness Huntington’s disease blood and brain show a common gene expression pattern and share an immune signature with Alzheimer’s disease Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease.Besides Huntington's disease, does brain-type creatine kinase play a role in other forms of hearing impairment resulting from a common pathological cause?Mutant huntingtin impairs immune cell migration in Huntington disease.Longitudinal transcriptomic dysregulation in the peripheral blood of transgenic Huntington's disease monkeys.Age-associated chromatin relaxation is enhanced in Huntington's disease mice.Pharmacology of epigenetics in brain disorders Blood-based biomarkers of Alzheimer's disease: challenging but feasible Brain-derived neurotrophic factor in patients with Huntington's disease Down-weighting overlapping genes improves gene set analysis.Downregulation of genes involved in metabolism and oxidative stress in the peripheral leukocytes of Huntington's disease patients.Dominant effects of the Huntington's disease HTT CAG repeat length are captured in gene-expression data sets by a continuous analysis mathematical modeling strategy Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspective Components of the endocannabinoid and dopamine systems are dysregulated in Huntington's disease: analysis of publicly available microarray datasets.Nitric oxide dysregulation in platelets from patients with advanced Huntington disease.HD CAGnome: a search tool for huntingtin CAG repeat length-correlated genes The role of the immune system in triplet repeat expansion diseases Huntington's Disease and Striatal Signaling.Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse Evaluating the SERCA2 and VEGF mRNAs as Potential Molecular Biomarkers of the Onset and Progression in Huntington's Disease Comparative study on gene set and pathway topology-based enrichment methods.Transcriptional hallmarks of Noonan syndrome and Noonan-like syndrome with loose anagen hair.Huntington's disease biomarker progression profile identified by transcriptome sequencing in peripheral blood.Association between gene expression of metabolizing enzymes and esophageal squamous cell carcinomas in China.Bone marrow transplantation confers modest benefits in mouse models of Huntington's disease.Characterization of forebrain neurons derived from late-onset Huntington's disease human embryonic stem cell lines.Manifestation of Huntington's disease pathology in human induced pluripotent stem cell-derived neurons.SPATIAL: A System-level PAThway Impact AnaLysis approach.Common disease signatures from gene expression analysis in Huntington's disease human blood and brain A large number of protein expression changes occur early in life and precede phenotype onset in a mouse model for huntington disease.Progress and prospects for genetic modification of nonhuman primate models in biomedical research.Chipping away at diagnostics for neurodegenerative diseases Identification of brain transcriptional variation reproduced in peripheral blood: an approach for mapping brain expression traits.RNA-Seq of Huntington's disease patient myeloid cells reveals innate transcriptional dysregulation associated with proinflammatory pathway activation.Large-scale hypomethylated blocks associated with Epstein-Barr virus-induced B-cell immortalization.Molecular mechanisms and potential therapeutical targets in Huntington's disease.Transcriptional profiling to identify biomarkers of disease and drug response.

P2860

Q24605880-2F61F090-5E96-467E-BDF4-D308A68F7F20 Q26828403-F630F553-1B85-4594-9EEE-964352D16840 Q28397964-AD10B1BB-7649-4003-9DCB-E9FB73370525 Q29248581-9AAAFAD3-1A1D-46E9-BACD-17D45B66815B Q30426968-D404F302-9C81-44E1-A2BE-88AC3E1A3844 Q30474238-B6FC3677-46DC-4972-A7CF-DE6FEC3DCBD0 Q30530945-12C53BFC-1A43-49D9-9EB0-A93E0A9B030C Q30543574-8A4604D5-6D51-4D69-800B-15568DCB5684 Q33563614-C2BF6255-F7A6-41A8-90F9-C3445C35D563 Q33673025-D168FCD1-3A47-4B1A-86C2-CD31DD933A79 Q33824444-854B7E69-F68B-4006-9918-77D75EDFEF01 Q33999072-C1797340-4722-4A9C-85B0-D0B23B386CC9 Q34309121-0AD93FB5-1058-4EB1-9BF3-6ED54F1DAE23 Q34431341-7D3409E4-BBB6-463B-9D37-6F9BBF010F79 Q34675885-45304C82-0AB4-4C97-A456-2C073042C017 Q35024695-422D7071-5BAE-4C74-8135-D5CCD7C40315 Q35049600-E509D329-7E92-4F91-AF0A-7C202FBBB045 Q35107991-77E9F2C1-EDBA-47D6-80DF-960EBC28E643 Q35153990-DF4BF174-FB6A-45F1-9E20-B73DD1E3DA2B Q35271805-96D5F18A-32C2-4F5C-AD5F-53420A6E5194 Q35286098-40243B33-B090-49C4-A0A1-88ADEF951194 Q35345762-BD55CE60-1E92-4168-A2BB-716D6EEC9E6E Q35542530-55C212B7-99B7-423E-895B-A4A2EABB1343 Q35816462-731F1A94-E195-4FC9-A393-6D87314D2E35 Q35903618-32215807-10A0-41AD-9EF4-48E2871986D3 Q36116666-A9635345-2812-4B35-BB3B-32B8E825C968 Q36308212-B35BBB46-0C79-4124-A3C8-360A42BD9576 Q36608360-852EA834-272B-4D72-8D14-69BF44D0C316 Q36742638-60460564-ABEF-4094-8082-0A1BCD555214 Q36800354-D290F2FF-8053-4A84-A45F-AECBC316EF3B Q37021596-C4F81686-0981-4D9E-A501-36332A88AEF4 Q37141460-7029E180-F813-424A-B0EE-E09FDDF2F6A5 Q37154448-D1FA7242-E1B9-4D67-B306-281DBBDCDD8B Q37271259-BB82A081-B38D-4EDA-BCBA-BA12BC8761A6 Q37366183-3AE08DEA-68FA-4351-B37C-5E62854C65F2 Q37397417-0B85C8FE-765B-42A8-8707-93374AC7B3CE Q37530090-C7A85C56-FCBA-4BCD-8EBD-A2DEE42088E7 Q37550182-2372765F-F375-405B-8548-A10BBEC68365 Q37776087-13455099-B04E-4165-8135-7565BFCD8D31 Q37844547-AA52DF38-51C1-43AB-8A2E-4B8DAF1DDA52

P2860

Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood.

http://www.wikidata.org/entity/Q30480013

description

2007 nî lūn-bûn

@nan

2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Analysis of potential transcri ...... s disease in peripheral blood.

@ast

Analysis of potential transcri ...... s disease in peripheral blood.

@en

type

label

Analysis of potential transcri ...... s disease in peripheral blood.

@ast

Analysis of potential transcri ...... s disease in peripheral blood.

@en

prefLabel

Analysis of potential transcri ...... s disease in peripheral blood.

@ast

Analysis of potential transcri ...... s disease in peripheral blood.

@en

P1433

Q30480013-472BC666-D844-44CD-B5F2-91E570CDBE38

P1476

Q30480013-48546B8A-9F80-4306-A87C-0293E85E0A25

P2093

Q30480013-25B42E24-9A0A-42A5-AEEC-CBD781B59637

Q30480013-58F46DA0-6295-43F1-B3B3-0F5513DE7E06

Q30480013-5985DF12-E7C4-4B2F-96BA-9E2CF3451303

Q30480013-9A18CD0A-E82F-43FB-952F-6DB8AD1CA5BA

Q30480013-B0BF2DA8-9BD6-49D6-B3A3-EF7E5F933C81

Q30480013-C4871015-6D97-43C0-AFCF-97EF48AF745D

Q30480013-F8DBE9AA-0CD2-4450-992C-0CBB8D57DD9A

P2860

Q30480013-1300C70B-D598-4EEC-891E-78B4CCCF93F7

Q30480013-2CA18C1B-365B-44C1-9BD3-FCC88FE94D8A

Q30480013-2CEF4B48-6781-4AA1-B2F8-D95EFD885135

Q30480013-384391F8-8047-47FE-BA83-4BE8D6C6F800

Q30480013-3A71A17D-283F-47F4-9424-772FAB62569F

Q30480013-3F4FA971-B43B-47F5-95FA-2D34DEF179B8

Q30480013-497473E4-6103-4388-B1CD-266201D92CC4

Q30480013-4D338222-2E6F-4986-8368-D4B157C289E2

Q30480013-530538A5-6E1D-4E97-AAFA-6B22677FE1D8

Q30480013-5B9F462E-6E8C-4565-8D87-37EC59A9AAD4

P304

Q30480013-409C4329-FEBE-4FEC-B91C-9E7EA1000E23

P31

Q30480013-46BAB5F8-E642-4755-A34B-4A27EDEC833E

P356

Q30480013-92B4C279-75A8-4010-B9AE-E11EF0D5D183

P407

Q30480013-C066D374-BBFE-4C3D-B1C2-CCD51421BC04

P433

Q30480013-3109F79C-AF97-4A2D-B0D6-A4EBFABDEEA9

P478

Q30480013-7FFF5CDE-8625-4412-AFD1-565ECFB805B8

P50

Q30480013-348B7AD6-71FE-4403-87A5-2D3B824DA815

Q30480013-41BC5BE3-BAD5-49A6-80BA-0A4630F15743

Q30480013-DB113249-1C70-4575-BA1B-4A863DBF17EF

P577

Q30480013-6A58605B-93BF-42CD-BC15-F4114DE89E30

P5875

Q30480013-98D9E954-12C9-4BCE-A310-30FB9144766F

P698

Q30480013-0CF87BE1-B35B-45FE-AFF9-1D91F6149DAA

P921

Q30480013-1A689513-98BB-4A2B-B0A3-07A01AE05761

Q30480013-C54ECC59-0557-4033-AF9A-E2B3EA8BEA2A

Q30480013-FF82D093-E52A-4239-9CAD-92FC78B1307D

P932

Q30480013-BEC965BA-3D59-44B2-BD91-21509209A9FC

P356

PNAS.0703652104

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Analysis of potential transcri ...... s disease in peripheral blood.

@en

P2093

Alexandre Kuhn

http://www.w3.org/2001/XMLSchema#string

Etienne Régulier

http://www.w3.org/2001/XMLSchema#string

Heike Runne

http://www.w3.org/2001/XMLSchema#string

Jeremy D Isaacs

http://www.w3.org/2001/XMLSchema#string

Mark Kristiansen

http://www.w3.org/2001/XMLSchema#string

Mauro Delorenzi

http://www.w3.org/2001/XMLSchema#string

Wirahpati Pratyaksha

http://www.w3.org/2001/XMLSchema#string

P2860

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

Linear models and empirical bayes methods for assessing differential expression in microarray experiments

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

affy--analysis of Affymetrix GeneChip data at the probe level

Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1.

Regional and cellular gene expression changes in human Huntington's disease brain.

Hypothalamic-endocrine aspects in Huntington's disease.

Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease.

Individuality and variation in gene expression patterns in human blood

Neuroinflammatory processes in Parkinson's disease.

P304

14424-14429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0703652104

http://www.w3.org/2001/XMLSchema#string

P407

P433

36

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

Sarah J. Tabrizi

Ruth Luthi-Carter

P577

2007-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6116668

http://www.w3.org/2001/XMLSchema#string

P698

17724341

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

1964868

http://www.w3.org/2001/XMLSchema#string